Search Results

Benzimidazole 250 g  | ≥98%

LKT Laboratories, Inc.

Microtubule polymerization inhibitor, potential topoisomerase I inhibitor.

More Information Supplier Page

×

Benzimidazole

Benzimidazole 50 g  | ≥98%

LKT Laboratories, Inc.

Microtubule polymerization inhibitor, potential topoisomerase I inhibitor.

More Information Supplier Page

×

Benzimidazole

Benzimidazole 5 g  | ≥98%

LKT Laboratories, Inc.

Microtubule polymerization inhibitor, potential topoisomerase I inhibitor.

More Information Supplier Page

×

Benzimidazole

Nicardipine 1 g  | ≥98%

LKT Laboratories, Inc.

Dihydropyridine; L-type Ca2+ channel blocker.

More Information Supplier Page

×

Nicardipine

Sitagliptin Phosphate Monohydrate 100 mg  | ≥98%

LKT Laboratories, Inc.

DPP4 inhibitor.

More Information Supplier Page

×

Sitagliptin Phosphate Monohydrate

PP-1 5 mg  | ≥98%

LKT Laboratories, Inc.

Src inhibitor.

More Information Supplier Page

×

PP-1

PP-1 25 mg  | ≥98%

LKT Laboratories, Inc.

Src inhibitor.

More Information Supplier Page

×

PP-1

Donepezil Hydrochloride 500 mg  | ≥98%

LKT Laboratories, Inc.

GSK3 and AChE inhibitor, potential σ1 agonist.

More Information Supplier Page

×

Donepezil Hydrochloride

Donepezil Hydrochloride 100 mg  | ≥98%

LKT Laboratories, Inc.

GSK3 and AChE inhibitor, potential σ1 agonist.

More Information Supplier Page

×

Donepezil Hydrochloride

Donepezil Hydrochloride 25 mg  | ≥98%

LKT Laboratories, Inc.

GSK3 and AChE inhibitor, potential σ1 agonist.

More Information Supplier Page

×

Donepezil Hydrochloride